In partnership with
First randomised T2T trial using endoscopy to guide dose escalation
Endoscopy can be delivered safely during the COVID-19 pandemic
Plecanatide effective for IBS with constipation
Sustained efficacy of anti-IL-23 in moderate-to-severe Crohn’s disease
Post-colonoscopy colorectal cancers in IBD patients
Adenoma detection rate improves over time
Dupilumab improves in diverse aspects of eosinophilic esophagitis
Filgotinib effective as maintenance treatment for ulcerative colitis
No improvements of remission with etrolizumab in ulcerative colitis
Sustained response to faecal microbiota transplantation
Risk factors for severe COVID-19 among IBD patients
Cholecystectomy does not affect mortality in elderly patients
Probiotic provides a potential adjuvant treatment to gluten-free diet
Possible causal link between eosinophilic inflammation and anxiety
Low-FODMAPs diet does not improve PPI-refractory GERD
Top image: @ iStockPhoto: ipopba
The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.
BACK TO TOP